Amneal Pharmaceuticals, Inc. (AMRX)

USD 7.69

(-4.71%)

Eps Summary of Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc.'s latest annual eps in 2023 was -0.48 USD , up 71.6% from previous year.
Amneal Pharmaceuticals, Inc.'s latest quarterly eps in 2024 Q1 was -0.30 USD , up 25.0% from previous quarter.
Amneal Pharmaceuticals, Inc. reported an annual eps of -1.69 USD in 2022, down -1307.14% from previous year.
Amneal Pharmaceuticals, Inc. reported an annual eps of 0.14 USD in 2021, down -70.21% from previous year.
Amneal Pharmaceuticals, Inc. reported a quarterly eps of 0.02 USD for 2024 Q2, up 106.67% from previous quarter.
Amneal Pharmaceuticals, Inc. reported a quarterly eps of N/A for 2023 FY, up 71.6% from previous quarter.

Annual Eps Chart of Amneal Pharmaceuticals, Inc. (2023 - 2014)

Historical Annual Eps of Amneal Pharmaceuticals, Inc. (2023 - 2014)

Year	Eps	Eps Growth
2023	-0.48 USD	71.6%
2022	-1.69 USD	-1307.14%
2021	0.14 USD	-70.21%
2020	0.47 USD	110.28%
2019	-4.57 USD	-243.61%
2018	-1.33 USD	-191.1%
2017	1.46 USD	-19.34%
2016	1.81 USD	101.11%
2015	0.90 USD	0.0%
2014	- USD	0.0%

Year	Eps	Eps Growth
2024 Q1	-0.30 USD	25.0%
2024 Q2	0.02 USD	106.67%
2023 FY	- USD	71.6%
2023 Q4	-0.40 USD	-766.67%
2023 Q1	-0.07 USD	-71.58%
2023 Q3	0.06 USD	-25.0%
2023 Q2	0.08 USD	220.48%
2022 Q1	-0.04 USD	-0.94%
2022 FY	- USD	-1307.14%
2022 Q4	-0.04 USD	-144.94%
2022 Q3	-0.02 USD	98.03%
2022 Q2	-0.80 USD	-1756.15%
2021 Q3	-0.03 USD	-128.4%
2021 Q4	-0.04 USD	-50.35%
2021 Q2	0.10 USD	100.0%
2021 Q1	0.05 USD	342.72%
2021 FY	- USD	-70.21%
2020 Q2	-0.08 USD	-110.44%
2020 Q4	-0.02 USD	66.12%
2020 FY	- USD	110.28%
2020 Q3	-0.06 USD	25.31%
2020 Q1	0.78 USD	439.13%
2019 Q2	-0.13 USD	64.86%
2019 Q4	-0.23 USD	88.67%
2019 FY	- USD	-243.61%
2019 Q1	-0.37 USD	-437.01%
2019 Q3	-2.03 USD	-1461.54%
2018 Q2	-1.73 USD	-484.44%
2018 FY	- USD	-191.1%
2018 Q4	-0.07 USD	-237.8%
2018 Q3	0.05 USD	102.89%
2018 Q1	0.45 USD	-16.67%
2017 FY	- USD	-19.34%
2017 Q1	- USD	-100.0%
2017 Q2	0.33 USD	0.0%
2017 Q3	0.23 USD	-30.3%
2017 Q4	0.54 USD	134.78%
2016 Q4	0.29 USD	0.0%
2016 FY	- USD	101.11%
2015 FY	- USD	0.0%
2014 FY	- USD	0.0%

Peer Eps Comparison of Amneal Pharmaceuticals, Inc.

Name	Eps	Eps Difference
Bausch Health Companies Inc.	-1.62 USD	70.37%
Catalent, Inc.	-5.76 USD	91.667%
Emergent BioSolutions Inc.	-14.85 USD	96.768%
Elanco Animal Health Incorporated	-2.50 USD	80.8%
Perrigo Company plc	-0.09 USD	-411.182%
Teva Pharmaceutical Industries Limited	-0.50 USD	4.0%
Zoetis Inc.	5.08 USD	109.449%